The tissue-protective properties of EVs expressing SerpinB3 could be exploited for the protection and recovery from acute and chronic ischemic damage, as in patients with myocardial infarction or with critical ischemia of the lower limbs. This evidence concerns the gene SERPINB3 and myocardial infarction.